Trials / Completed
CompletedNCT01526863
Hydrolyzed Egg and Tolerance Induction
Assessment of the Effect of an HA Egg Administration for 6 Months on the Tolerance Induction to Egg in Children Allergic to Egg as Compared to a Placebo
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 12 Months – 66 Months
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to assess the effect of hydrolyzed egg orally administered on oral tolerance induction to egg in children allergic to egg as compared to a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | HA egg | Daily dose of HA egg or placebo for 6 months |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2012-02-06
- Last updated
- 2015-01-16
Locations
3 sites across 3 countries: Greece, Italy, Switzerland
Source: ClinicalTrials.gov record NCT01526863. Inclusion in this directory is not an endorsement.